首页> 外文期刊>The Open Pathology Journal >Interrogation of Chromosome 13q12-14 in Esophageal Squamous CellCarcinoma
【24h】

Interrogation of Chromosome 13q12-14 in Esophageal Squamous CellCarcinoma

机译:食管鳞状细胞癌中染色体13q12-14的询问

获取原文
       

摘要

Previous studies of esophageal squamous cell carcinoma (ESCC) suggested chromosome region 13q12-14harbors a familial ESCC gene. DNA sequencing of the BRCA2 gene, located on 13q12, showed evidence of both germlineand tumor specific alterations but the frequency of changes was low and did not fit the classic Knudsen two-hit geneinactivation model. To further investigate chromosome 13q12-14 in ESCC, quantitative expression measurements wereperformed on BRCA2 and 11 neighboring genes in matched normal epithelium and tumor from 17 cases. Transcriptanalysis showed normal levels of five genes, tumor down-regulation of two genes (TNFRS19 and TPT1), and tumor upregulationof five genes, including BRCA2. No evidence of BRCA2 loss-of-function was detected based on reducedmRNA in tumor cells. Between 13q12.3 (KATNAL1) and 13q12.3-q13 (CCNA1) five adjacent genes showed increasedmRNA expression raising the possibility of a DNA amplicon; however, qPCR analysis showed normal DNA amounts inthis region. CCNA1 transcript was significantly up-regulated in tumors and was thus further interrogated at the proteinlevel by immunohistochemistry. CCNA1 staining was restricted to normal basal epithelium and was not expressed inmore superficial, differentiated regions. In contrast, the CCNA1 protein was ubiquitously and highly expressed throughouttumor foci. Overall, these data from a relatively small number of cases (17) suggest that TNFRS19 and TPT1 deservefurther investigation as candidate tumor suppressor genes in esophageal cancer in a larger patient series; BRCA2 mRNA isincreased in the tumors, likely as a compensatory response to the marked DNA damage that is present in these lesions;and, CCNA1 was identified as a novel up-regulated gene in ESCC.
机译:食管鳞状细胞癌(ESCC)的先前研究表明,染色体区域13q12-14带有家族性ESCC基因。位于13q12处的BRCA2基因的DNA测序显示出种系和肿瘤特异性改变的证据,但是改变的频率很低,不适合经典的克努森两次命中基因灭活模型。为了进一步研究ESCC中的染色体13q12-14,对17例匹配的正常上皮和肿瘤中的BRCA2和11个邻近基因进行了定量表达测量。转录分析显示五个基因的正常水平,两个基因(TNFRS19和TPT1)的肿瘤下调以及五个基因(包括BRCA2)的肿瘤上调。基于肿瘤细胞中减少的mRNA,未检测到BRCA2功能丧失的证据。在13q12.3(KATNAL1)和13q12.3-q13(CCNA1)之间,五个相邻的基因显示mRNA表达增加,从而增加了DNA扩增子的可能性。但是,qPCR分析显示该区域的DNA量正常。 CCNA1转录物在肿瘤中显着上调,因此通过免疫组织化学进一步在蛋白质水平上被询问。 CCNA1染色仅限于正常的基底上皮,在较浅的,分化的区域中不表达。相反,CCNA1蛋白在整个肿瘤灶中无处不在且高度表达。总的来说,这些来自相对少数病例的数据(17)表明,TNFRS19和TPT1作为食管癌中较大患者系列的候选抑癌基因值得进一步研究。 BRCA2 mRNA在肿瘤中增加,可能是对这些病变中存在的明显DNA损伤的代偿性反应;并且CCNA1被鉴定为ESCC中一个新的上调基因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号